Results for tag: "Ibudilast"

Ibudilast is a drug used to treat immune disorders. It is a phosphodiesterase inhibitor and a non-selective agonist of the adenosine A2A receptor. Ibudilast is used to treat a variety of conditions, including asthma, multiple sclerosis, and chronic obstructive pulmonary disease. It is also used to reduce inflammation and improve the function of the immune system. Ibudilast has been studied for its potential to treat other conditions, such as Alzheimer's disease, Parkinson's disease, and stroke. Ibudilast is approved for use in Japan and South Korea, and is being studied in clinical trials in the United States. It is available in oral and intravenous formulations. Ibudilast is generally well-tolerated, with the most common side effects being headache, nausea, and dizziness. The Ibudilast market is a growing one, with a number of companies developing and marketing the drug. These include Otsuka Pharmaceuticals, Kyowa Hakko Kirin, and Mitsubishi Tanabe Pharma. Other companies, such as Novartis, are also researching the potential of Ibudilast for treating various immune disorders. Show Less Read more